NEW YORK, August 29, 2016 /PRNewswire/ --
Stock-Callers.com this morning takes a look at the Healthcare sector whichwas one of the best performing sectors in afternoon trading on Friday, August 26, 2016. Let us now see how the following stocks performed at the closing bell: Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare
Brookdale Senior Living
Brentwood, Tennessee headquartered Brookdale Senior Living Inc.'s stock finished 0.77% lower at $16.84 with a total volume of 1.92 million shares traded. Shares of the Company, which owns and operates senior living communities in the US, are trading above their 50-day moving average by 0.20%. The stock has a Relative Strength Index (RSI) of 47.72.
On August 8th, 2016, the company reported that total revenue for Q2 2016 was $1.3 billion up 1.7%, compared to $1.2 billion for the prior year period. Average monthly revenue per occupied unit for the consolidated senior housing portfolio was $4,476 in Q2 2016, an increase of 3.3% compared to Q2 2015. Weighted average occupancy for all consolidated communities in Q2 2016 was 85.8%, compared to 86.5% in Q2 2015. Brookdale's consolidated operating margin was 34.3% for Q2 2016 versus 33.4% for Q2 2015. Net loss attributable to Brookdale common stockholders for Q2 2016 was $35.5 million, or $0.19 per share, versus net loss attributable to Brookdale's common stockholders of $84.5 million, or $0.46 per share, for Q2 2015. BKD complete research report is just a click away and free at:
Envision Healthcare Holdings
Shares in Greenwood Village, Colorado headquartered Envision Healthcare Holdings Inc. ended the session 0.67% higher at $20.90 and with a total volume of 1.48 million shares traded. The stock is trading 11.61% below its 200-day moving average. Shares of the Company, which provides physician-led outsourced medical services to consumers, hospitals, healthcare systems, health plans, and government entities in the US, have an RSI of 33.38.
On August 3rd, 2016, the company generated net revenue of $1.64 billion in Q2 2016; an increase of 21.2%, driven by contributions from acquisitions of 16.7%, and organic growth of 4.5%. Net income was $28.4 million in Q2 2016, compared to $52.4 million in the year ago period. Envision Healthcare earned $0.15 per diluted share on a GAAP basis and adjusted diluted EPS was $0.34 for Q2 2016. The complimentary report on EVHC can be downloaded at:
Louisville, Kentucky headquartered Kindred Healthcare Inc.'s stock fell 0.38%, closing the session at $10.37 and with a total volume of 575,216 shares traded. Shares of the Company, which provides healthcare services in the US, are trading 8.87% below their 50-day moving average. The stock has an RSI of 39.16.
On August 4th, 2016, Kindred Healthcare reported that consolidated revenues were $1.84 billion in Q2 2016, a 0.5% increase on y-o-y basis, while GAAP income from continuing operations increased 2% to $34.4 million from $33.7 million in Q2 2015. The company's GAAP diluted earnings per share ("EPS") from continuing operations was $0.23 and core diluted EPS from continuing operations was $0.38 based upon 87.5 million weighted average diluted shares. In the same period a year ago, the company reported GAAP diluted EPS of $0.25, while core diluted EPS was $0.39 based upon 86.4 million weighted average diluted shares. Sign up for your complimentary research report on KND at:
On Friday, Lewisville, Texas-based Adeptus Health Inc.'s stock closed the session 1.63% lower at $42.75 with a total volume of 163,832 shares traded. Shares of the Company, which owns and operates a network of independent freestanding emergency rooms in the US, are trading below their 50-day moving average by 11.41%. The stock has an RSI of 41.40.
On July 28th, 2016, Adeptus Health announced that Frank R. Williams, Jr. will join the company's executive leadership as Executive Vice President and Chief Financial Officer. Williams will succeed Timothy L. Fielding, who has decided to pursue other business interests. Mr. Fielding will remain with the company through the end of September to ensure a smooth transition. Mr. Williams, most recently, was the Senior Vice President and Senior Managing Director-Acquisitions for Medical Properties Trust for the past five years. He brings more than 20 years of investment banking and finance experience as well as substantial healthcare industry expertise to the role of CFO. Get free access to your research report on ADPT at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Adult immunization is needed for adults whose mandatory childhood vaccines were either missed out ...
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast ...View All